Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis

NCT02709005 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

NIH

Sponsor class

Conditions

Bacterial Vaginosis

Interventions

DRUG: 5% Monolaurin Vaginal Gel
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)